GD-iEXo-002
/ Guidon Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 10, 2024
Treatment of children epileptic encephalopathy with iPSC derived exosomes (GD-iExo-002): a clinical exploratory study
(ChiCTR)
- P=N/A | N=30 | Recruiting | Sponsor: Capital Institute of Pediatrics; Guidon Pharmaceutics Ltd.
New trial • CNS Disorders • Epilepsy
1 to 1
Of
1
Go to page
1